As of 2025-11-19, the Intrinsic Value of Isofol Medical AB (publ) (ISOFOL.ST) is -2.11 SEK. This ISOFOL.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.70 SEK, the upside of Isofol Medical AB (publ) is -403.89%.
Based on its market price of 0.70 SEK and our intrinsic valuation, Isofol Medical AB (publ) (ISOFOL.ST) is overvalued by 403.89%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.11 - -2.11 | -2.11 | -403.89% |
| P/E | (5.15) - (5.99) | (5.54) | -897.5% |
| DDM - Stable | (1.46) - (7.56) | (4.51) | -748.9% |
| DDM - Multi | (1.10) - (4.63) | (1.80) | -358.9% |
| Market Cap (mil) | 195.37 |
| Beta | -0.46 |
| Outstanding shares (mil) | 281.11 |
| Enterprise Value (mil) | 129.72 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.56% |
| Cost of Debt | 5.00% |
| WACC | 6.76% |